{"results":[{"description":"Fake medicines are illegally produced products that may contain incorrect ingredients, no active ingredients, or harmful substances. \r\n","format":"news_story","link":"/government/news/fake-mounjaro-tirzepatide-kwikpen-15mg-pre-filled-pens","organisations":[{"organisation_type":"executive_agency","organisation_state":"live","superseding_organisations":[],"acronym":"MHRA","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","link":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","parent_organisations":["department-of-health-and-social-care"],"superseded_organisations":[],"analytics_identifier":"EA63","title":"Medicines and Healthcare products Regulatory Agency","organisation_crest":"single-identity","organisation_brand":"department-of-health-social-care","child_organisations":[],"logo_formatted_title":"Medicines & Healthcare products
Regulatory Agency","slug":"medicines-and-healthcare-products-regulatory-agency","public_timestamp":"2025-06-25T11:21:52Z"}],"public_timestamp":"2026-02-24T18:08:00Z","title":"Fake Mounjaro (tirzepatide) KwikPen 15mg pre-filled pens","world_locations":[],"topical_events":[],"organisation_content_ids":["240f72bd-9a4d-4f39-94d9-77235cadde8e"],"expanded_organisations":[{"organisation_type":"executive_agency","organisation_state":"live","superseding_organisations":[],"acronym":"MHRA","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","link":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","parent_organisations":["department-of-health-and-social-care"],"superseded_organisations":[],"analytics_identifier":"EA63","title":"Medicines and Healthcare products Regulatory Agency","organisation_crest":"single-identity","organisation_brand":"department-of-health-social-care","child_organisations":[],"logo_formatted_title":"Medicines & Healthcare products
Regulatory Agency","slug":"medicines-and-healthcare-products-regulatory-agency","public_timestamp":"2025-06-25T11:21:52Z"}],"index":"govuk","es_score":0.06342594,"_id":"/government/news/fake-mounjaro-tirzepatide-kwikpen-15mg-pre-filled-pens","elasticsearch_type":"edition","document_type":"edition"},{"description":"For the first time in the UK, obese patients and people who are overweight with weight-related health problems could now have access to Mounjaro, currently used for Type 2 diabetes, to help manage their weight and support weight loss. ","format":"press_release","link":"/government/news/mhra-authorises-diabetes-drug-mounjaro-tirzepatide-for-weight-management-and-weight-loss","organisations":[{"organisation_type":"executive_agency","organisation_state":"live","superseding_organisations":[],"acronym":"MHRA","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","link":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","parent_organisations":["department-of-health-and-social-care"],"superseded_organisations":[],"analytics_identifier":"EA63","title":"Medicines and Healthcare products Regulatory Agency","organisation_crest":"single-identity","organisation_brand":"department-of-health-social-care","child_organisations":[],"logo_formatted_title":"Medicines & Healthcare products
Regulatory Agency","slug":"medicines-and-healthcare-products-regulatory-agency","public_timestamp":"2025-06-25T11:21:52Z"}],"public_timestamp":"2023-11-08T20:06:27Z","title":"MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss","world_locations":[],"topical_events":[],"organisation_content_ids":["240f72bd-9a4d-4f39-94d9-77235cadde8e"],"expanded_organisations":[{"organisation_type":"executive_agency","organisation_state":"live","superseding_organisations":[],"acronym":"MHRA","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","link":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","parent_organisations":["department-of-health-and-social-care"],"superseded_organisations":[],"analytics_identifier":"EA63","title":"Medicines and Healthcare products Regulatory Agency","organisation_crest":"single-identity","organisation_brand":"department-of-health-social-care","child_organisations":[],"logo_formatted_title":"Medicines & Healthcare products
Regulatory Agency","slug":"medicines-and-healthcare-products-regulatory-agency","public_timestamp":"2025-06-25T11:21:52Z"}],"index":"govuk","es_score":0.060995884,"_id":"/government/news/mhra-authorises-diabetes-drug-mounjaro-tirzepatide-for-weight-management-and-weight-loss","elasticsearch_type":"edition","document_type":"edition"},{"description":"A falsified version of Mounjaro (tirzepatide) KwikPen 15mg solution for injection has been found supplied through one online pharmacy in the UK. The falsified product is labelled with batch D873576 and applies to Mounjaro KwikPen 15mg solution for injection in pre-filled pen only. \r\n\r\n","format":"drug_safety_update","link":"/drug-safety-update/falsified-mounjaro-kwikpen-15mg-pre-filled-pens","organisations":[{"organisation_type":"executive_agency","organisation_state":"live","superseding_organisations":[],"acronym":"MHRA","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","link":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","parent_organisations":["department-of-health-and-social-care"],"superseded_organisations":[],"analytics_identifier":"EA63","title":"Medicines and Healthcare products Regulatory Agency","organisation_crest":"single-identity","organisation_brand":"department-of-health-social-care","child_organisations":[],"logo_formatted_title":"Medicines & Healthcare products
Regulatory Agency","slug":"medicines-and-healthcare-products-regulatory-agency","public_timestamp":"2025-06-25T11:21:52Z"}],"public_timestamp":"2026-02-24T14:00:08Z","title":"Falsified Mounjaro KwikPen 15mg pre-filled pens ","topical_events":[],"organisation_content_ids":["240f72bd-9a4d-4f39-94d9-77235cadde8e"],"expanded_organisations":[{"organisation_type":"executive_agency","organisation_state":"live","superseding_organisations":[],"acronym":"MHRA","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","link":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","parent_organisations":["department-of-health-and-social-care"],"superseded_organisations":[],"analytics_identifier":"EA63","title":"Medicines and Healthcare products Regulatory Agency","organisation_crest":"single-identity","organisation_brand":"department-of-health-social-care","child_organisations":[],"logo_formatted_title":"Medicines & Healthcare products
Regulatory Agency","slug":"medicines-and-healthcare-products-regulatory-agency","public_timestamp":"2025-06-25T11:21:52Z"}],"index":"govuk","es_score":0.03516088,"_id":"/drug-safety-update/falsified-mounjaro-kwikpen-15mg-pre-filled-pens","elasticsearch_type":"drug_safety_update","document_type":"drug_safety_update"},{"description":"Fake weight loss medicines worth approximately £2 million were seized last night in a raid executed by the Medicines and Healthcare products Regulatory Agency (MHRA) and West Midlands Police.","format":"press_release","link":"/government/news/counterfeit-weight-loss-pens-worth-2-million-seized-by-mhra-and-west-mids-police","organisations":[{"organisation_type":"executive_agency","organisation_state":"live","superseding_organisations":[],"acronym":"MHRA","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","link":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","parent_organisations":["department-of-health-and-social-care"],"superseded_organisations":[],"analytics_identifier":"EA63","title":"Medicines and Healthcare products Regulatory Agency","organisation_crest":"single-identity","organisation_brand":"department-of-health-social-care","child_organisations":[],"logo_formatted_title":"Medicines & Healthcare products
Regulatory Agency","slug":"medicines-and-healthcare-products-regulatory-agency","public_timestamp":"2025-06-25T11:21:52Z"}],"public_timestamp":"2026-10-15T13:36:00Z","title":"Counterfeit weight loss pens worth £2 million seized by MHRA and West Midlands Police","world_locations":[],"topical_events":[],"organisation_content_ids":["240f72bd-9a4d-4f39-94d9-77235cadde8e"],"expanded_organisations":[{"organisation_type":"executive_agency","organisation_state":"live","superseding_organisations":[],"acronym":"MHRA","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","link":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","parent_organisations":["department-of-health-and-social-care"],"superseded_organisations":[],"analytics_identifier":"EA63","title":"Medicines and Healthcare products Regulatory Agency","organisation_crest":"single-identity","organisation_brand":"department-of-health-social-care","child_organisations":[],"logo_formatted_title":"Medicines & Healthcare products
Regulatory Agency","slug":"medicines-and-healthcare-products-regulatory-agency","public_timestamp":"2025-06-25T11:21:52Z"}],"index":"govuk","es_score":0.030466529,"_id":"/government/news/counterfeit-weight-loss-pens-worth-2-million-seized-by-mhra-and-west-mids-police","elasticsearch_type":"edition","document_type":"edition"},{"description":"The new presentation of Mounjaro gives four doses for once-a-week treatment over a month.","format":"press_release","link":"/government/news/four-dose-mounjaro-kwikpen-approved-by-mhra-for-diabetes-and-weight-management","organisations":[{"organisation_type":"executive_agency","organisation_state":"live","superseding_organisations":[],"acronym":"MHRA","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","link":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","parent_organisations":["department-of-health-and-social-care"],"superseded_organisations":[],"analytics_identifier":"EA63","title":"Medicines and Healthcare products Regulatory Agency","organisation_crest":"single-identity","organisation_brand":"department-of-health-social-care","child_organisations":[],"logo_formatted_title":"Medicines & Healthcare products
Regulatory Agency","slug":"medicines-and-healthcare-products-regulatory-agency","public_timestamp":"2025-06-25T11:21:52Z"}],"public_timestamp":"2024-01-25T17:00:19Z","title":"Four-dose Mounjaro “KwikPen” approved by MHRA for diabetes and weight management","world_locations":[],"topical_events":[],"organisation_content_ids":["240f72bd-9a4d-4f39-94d9-77235cadde8e"],"expanded_organisations":[{"organisation_type":"executive_agency","organisation_state":"live","superseding_organisations":[],"acronym":"MHRA","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","link":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","parent_organisations":["department-of-health-and-social-care"],"superseded_organisations":[],"analytics_identifier":"EA63","title":"Medicines and Healthcare products Regulatory Agency","organisation_crest":"single-identity","organisation_brand":"department-of-health-social-care","child_organisations":[],"logo_formatted_title":"Medicines & Healthcare products
Regulatory Agency","slug":"medicines-and-healthcare-products-regulatory-agency","public_timestamp":"2025-06-25T11:21:52Z"}],"index":"govuk","es_score":0.019124547,"_id":"/government/news/four-dose-mounjaro-kwikpen-approved-by-mhra-for-diabetes-and-weight-management","elasticsearch_type":"edition","document_type":"edition"},{"description":"The product information for all Glucagon-Like Peptide-1 (GLP-1) receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists has been further updated to highlight the potential risk of severe acute pancreatitis with these products, including rare reports of necrotising and fatal pancreatitis.","format":"drug_safety_update","link":"/drug-safety-update/glp-1-receptor-agonists-and-dual-glp-1-slash-gip-receptor-agonists-strengthened-warnings-on-acute-pancreatitis-including-necrotising-and-fatal-cases","organisations":[{"organisation_type":"executive_agency","organisation_state":"live","superseding_organisations":[],"acronym":"MHRA","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","link":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","parent_organisations":["department-of-health-and-social-care"],"superseded_organisations":[],"analytics_identifier":"EA63","title":"Medicines and Healthcare products Regulatory Agency","organisation_crest":"single-identity","organisation_brand":"department-of-health-social-care","child_organisations":[],"logo_formatted_title":"Medicines & Healthcare products
Regulatory Agency","slug":"medicines-and-healthcare-products-regulatory-agency","public_timestamp":"2025-06-25T11:21:52Z"}],"public_timestamp":"2026-01-29T14:07:50Z","title":"GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists: strengthened warnings on acute pancreatitis, including necrotising and fatal cases","topical_events":[],"organisation_content_ids":["240f72bd-9a4d-4f39-94d9-77235cadde8e"],"expanded_organisations":[{"organisation_type":"executive_agency","organisation_state":"live","superseding_organisations":[],"acronym":"MHRA","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","link":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","parent_organisations":["department-of-health-and-social-care"],"superseded_organisations":[],"analytics_identifier":"EA63","title":"Medicines and Healthcare products Regulatory Agency","organisation_crest":"single-identity","organisation_brand":"department-of-health-social-care","child_organisations":[],"logo_formatted_title":"Medicines & Healthcare products
Regulatory Agency","slug":"medicines-and-healthcare-products-regulatory-agency","public_timestamp":"2025-06-25T11:21:52Z"}],"index":"govuk","es_score":0.016388476,"_id":"/drug-safety-update/glp-1-receptor-agonists-and-dual-glp-1-slash-gip-receptor-agonists-strengthened-warnings-on-acute-pancreatitis-including-necrotising-and-fatal-cases","elasticsearch_type":"drug_safety_update","document_type":"drug_safety_update"},{"description":"Guidance on the safe and effective use of GLP-1 medicines for weight loss and diabetes.","display_type":"Guidance","format":"guidance","link":"/government/publications/glp-1-medicines-for-weight-loss-and-diabetes-what-you-need-to-know","organisations":[{"organisation_type":"executive_agency","organisation_state":"live","superseding_organisations":[],"acronym":"MHRA","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","link":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","parent_organisations":["department-of-health-and-social-care"],"superseded_organisations":[],"analytics_identifier":"EA63","title":"Medicines and Healthcare products Regulatory Agency","organisation_crest":"single-identity","organisation_brand":"department-of-health-social-care","child_organisations":[],"logo_formatted_title":"Medicines & Healthcare products
Regulatory Agency","slug":"medicines-and-healthcare-products-regulatory-agency","public_timestamp":"2025-06-25T11:21:52Z"}],"public_timestamp":"2026-02-05T13:31:40Z","title":"GLP-1 medicines for weight loss and diabetes: what you need to know","world_locations":[],"topical_events":[],"organisation_content_ids":["240f72bd-9a4d-4f39-94d9-77235cadde8e"],"expanded_organisations":[{"organisation_type":"executive_agency","organisation_state":"live","superseding_organisations":[],"acronym":"MHRA","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","link":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","parent_organisations":["department-of-health-and-social-care"],"superseded_organisations":[],"analytics_identifier":"EA63","title":"Medicines and Healthcare products Regulatory Agency","organisation_crest":"single-identity","organisation_brand":"department-of-health-social-care","child_organisations":[],"logo_formatted_title":"Medicines & Healthcare products
Regulatory Agency","slug":"medicines-and-healthcare-products-regulatory-agency","public_timestamp":"2025-06-25T11:21:52Z"}],"index":"govuk","es_score":0.015511484,"_id":"/government/publications/glp-1-medicines-for-weight-loss-and-diabetes-what-you-need-to-know","elasticsearch_type":"edition","document_type":"edition"},{"description":"Summary of the latest safety advice for medicines and medical device users","format":"medical_safety_alert","link":"/drug-device-alerts/mhra-safety-roundup-february-2026","organisations":[{"organisation_type":"executive_agency","organisation_state":"live","superseding_organisations":[],"acronym":"MHRA","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","link":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","parent_organisations":["department-of-health-and-social-care"],"superseded_organisations":[],"analytics_identifier":"EA63","title":"Medicines and Healthcare products Regulatory Agency","organisation_crest":"single-identity","organisation_brand":"department-of-health-social-care","child_organisations":[],"logo_formatted_title":"Medicines & Healthcare products
Regulatory Agency","slug":"medicines-and-healthcare-products-regulatory-agency","public_timestamp":"2025-06-25T11:21:52Z"}],"public_timestamp":"2026-02-25T11:12:50Z","title":"MHRA Safety Roundup: February 2026","topical_events":[],"organisation_content_ids":["240f72bd-9a4d-4f39-94d9-77235cadde8e"],"expanded_organisations":[{"organisation_type":"executive_agency","organisation_state":"live","superseding_organisations":[],"acronym":"MHRA","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","link":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","parent_organisations":["department-of-health-and-social-care"],"superseded_organisations":[],"analytics_identifier":"EA63","title":"Medicines and Healthcare products Regulatory Agency","organisation_crest":"single-identity","organisation_brand":"department-of-health-social-care","child_organisations":[],"logo_formatted_title":"Medicines & Healthcare products
Regulatory Agency","slug":"medicines-and-healthcare-products-regulatory-agency","public_timestamp":"2025-06-25T11:21:52Z"}],"index":"govuk","es_score":0.014543221,"_id":"/drug-device-alerts/mhra-safety-roundup-february-2026","elasticsearch_type":"medical_safety_alert","document_type":"medical_safety_alert"},{"description":"Healthcare professionals are reminded to inform patients about the common and serious side effects associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs). ","format":"drug_safety_update","link":"/drug-safety-update/glp-1-receptor-agonists-reminder-of-the-potential-side-effects-and-to-be-aware-of-the-potential-for-misuse","organisations":[{"organisation_type":"executive_agency","organisation_state":"live","superseding_organisations":[],"acronym":"MHRA","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","link":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","parent_organisations":["department-of-health-and-social-care"],"superseded_organisations":[],"analytics_identifier":"EA63","title":"Medicines and Healthcare products Regulatory Agency","organisation_crest":"single-identity","organisation_brand":"department-of-health-social-care","child_organisations":[],"logo_formatted_title":"Medicines & Healthcare products
Regulatory Agency","slug":"medicines-and-healthcare-products-regulatory-agency","public_timestamp":"2025-06-25T11:21:52Z"}],"public_timestamp":"2024-10-24T10:00:32Z","title":"GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse","topical_events":[],"organisation_content_ids":["240f72bd-9a4d-4f39-94d9-77235cadde8e"],"expanded_organisations":[{"organisation_type":"executive_agency","organisation_state":"live","superseding_organisations":[],"acronym":"MHRA","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","link":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","parent_organisations":["department-of-health-and-social-care"],"superseded_organisations":[],"analytics_identifier":"EA63","title":"Medicines and Healthcare products Regulatory Agency","organisation_crest":"single-identity","organisation_brand":"department-of-health-social-care","child_organisations":[],"logo_formatted_title":"Medicines & Healthcare products
Regulatory Agency","slug":"medicines-and-healthcare-products-regulatory-agency","public_timestamp":"2025-06-25T11:21:52Z"}],"index":"govuk","es_score":0.013624552,"_id":"/drug-safety-update/glp-1-receptor-agonists-reminder-of-the-potential-side-effects-and-to-be-aware-of-the-potential-for-misuse","elasticsearch_type":"drug_safety_update","document_type":"drug_safety_update"},{"description":"Healthcare professionals should be aware of the potential risk of pulmonary aspiration in patients using GLP-1 or dual GIP/GLP-1 receptor agonists who undergo surgery or procedures with general anaesthesia or deep sedation.","format":"drug_safety_update","link":"/drug-safety-update/glp-1-and-dual-gip-slash-glp-1-receptor-agonists-potential-risk-of-pulmonary-aspiration-during-general-anaesthesia-or-deep-sedation","organisations":[{"organisation_type":"executive_agency","organisation_state":"live","superseding_organisations":[],"acronym":"MHRA","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","link":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","parent_organisations":["department-of-health-and-social-care"],"superseded_organisations":[],"analytics_identifier":"EA63","title":"Medicines and Healthcare products Regulatory Agency","organisation_crest":"single-identity","organisation_brand":"department-of-health-social-care","child_organisations":[],"logo_formatted_title":"Medicines & Healthcare products
Regulatory Agency","slug":"medicines-and-healthcare-products-regulatory-agency","public_timestamp":"2025-06-25T11:21:52Z"}],"public_timestamp":"2025-01-28T14:00:20Z","title":"GLP-1 and dual GIP/GLP-1 receptor agonists: potential risk of pulmonary aspiration during general anaesthesia or deep sedation ","topical_events":[],"organisation_content_ids":["240f72bd-9a4d-4f39-94d9-77235cadde8e"],"expanded_organisations":[{"organisation_type":"executive_agency","organisation_state":"live","superseding_organisations":[],"acronym":"MHRA","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","link":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","parent_organisations":["department-of-health-and-social-care"],"superseded_organisations":[],"analytics_identifier":"EA63","title":"Medicines and Healthcare products Regulatory Agency","organisation_crest":"single-identity","organisation_brand":"department-of-health-social-care","child_organisations":[],"logo_formatted_title":"Medicines & Healthcare products
Regulatory Agency","slug":"medicines-and-healthcare-products-regulatory-agency","public_timestamp":"2025-06-25T11:21:52Z"}],"index":"govuk","es_score":0.013364805,"_id":"/drug-safety-update/glp-1-and-dual-gip-slash-glp-1-receptor-agonists-potential-risk-of-pulmonary-aspiration-during-general-anaesthesia-or-deep-sedation","elasticsearch_type":"drug_safety_update","document_type":"drug_safety_update"}],"total":26,"start":0,"aggregates":{},"suggested_queries":[],"suggested_autocomplete":[],"es_cluster":"A"}